(Q42714258)

5 November 2017

Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans (English)

1 reference

5 November 2017

Salman R Khetani

1

1 reference

5 November 2017

Chitra Kanchagar

2

1 reference

5 November 2017

Okechukwu Ukairo

3

1 reference

5 November 2017

Stacy Krzyzewski

4

1 reference

5 November 2017

Amanda Moore

5

1 reference

5 November 2017

Julianne Shi

6

1 reference

5 November 2017

Simon Aoyama

7

1 reference

5 November 2017

Michael Aleo

8

1 reference

5 November 2017

Yvonne Will

9

1 reference

5 November 2017

14 November 2012

1 reference

5 November 2017

Toxicological Sciences

1 reference

5 November 2017

132

1 reference

5 November 2017

107-117

1 reference

5 November 2017

1

1 reference

Investigation of the hepatotoxicity profile of chemical entities using Liverbeads and WIF-B9 in vitro models.

5 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Hepatotoxicity of phenacetin and paracetamol in the Gunn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

FDA-approved drug labeling for the study of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Biochemical mechanisms in drug-induced liver injury: certainties and doubts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Cytotoxicity of mebendazole against established cell lines from the human, rat, and mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Epigenetic changes in the rat livers induced by pyrazinamide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Differential sensitivity and responsiveness of three human cell lines HepG2, 1321N1 and HEK 293 to cadmium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Imipramine- and mianserin-induced acute cell injury in primary cultured rat hepatocytes: implication of different cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Cutting the cost of drug development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Idiosyncratic toxicity: a convergence of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

Cellular imaging predictions of clinical drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFS326

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFS326

1 reference

5 November 2017

1 reference